A naturally occurring molecule that helps the brain clear away damaged blood cells could lead to new treatments for one of the deadliest forms of stroke, according to research led by scientists at the University of Manchester.
The study, published in the Journal of Neuroinflammation and funded by the Medical Research Council, focuses on intracerebral haemorrhage (ICH) — a type of stroke that occurs when a blood vessel bursts and bleeds directly into the brain. The leaked blood releases substances such as iron that cause further damage, and effective treatments remain limited, the university reported.
The researchers identified a biological process in both humans and mice that appears to help the brain cope with the aftermath of bleeding and improve recovery. The process centres on an enzyme called cholesterol 25-hydroxylase (CH25H), which converts cholesterol into a molecule known as 25-hydroxycholesterol (25HC).
According to the university, the team found increased levels of CH25H in brain tissue from people who had suffered an ICH, particularly in immune cells surrounding the site of the bleed. The enzyme appeared to help the brain's resident immune cells — called microglia — engulf and remove red blood cells released into brain tissue after a haemorrhage. It also influenced genes involved in clearing cellular debris and processing fats and cholesterol within the microglia.
This clean-up process can be critical, the researchers said, because when red blood cells break down they can contribute to further brain damage after the initial stroke.
In experiments with mice, those genetically lacking the Ch25h enzyme experienced greater iron accumulation and tissue damage, and exhibited more severe neurological outcomes after a brain bleed was induced in the lab. In contrast, administering 25HC to mice enhanced their neurological recovery and diminished indicators of brain injury. Without Ch25h, immune cells showed reduced efficiency in consuming red blood cells and built up more lipid deposits inside them. Giving 25HC boosted the cells' capacity to consume red blood cells and lessened the accumulation of lipid deposits, providing further evidence for the effect, the university said.
Co-lead author Professor Catherine Lawrence from the University of Manchester said: "Our research suggests that the enzyme CH25H and the molecule it produces, 25HC, help the brain's immune cells clear away damaged red blood cells after a haemorrhagic stroke, limiting the harmful effects of bleeding and highlighting a promising natural process that could potentially be harnessed to improve recovery for patients."
Co-lead author Dr Paul Kasher added: "These findings reveal an important part of the brain's natural clean-up response after haemorrhagic stroke, showing how 25HC can help immune cells remove damaging material more effectively, and while further research is needed, targeting this pathway could ultimately offer a new approach to treating this devastating and often deadly condition."
Kasher cautioned: "Further research will be needed to establish whether targeting this pathway could eventually be developed into a safe and effective treatment for patients."
For university students, particularly those studying biomedical sciences, neuroscience, or medicine, this research highlights a promising avenue for future therapies targeting a condition with few current options. It also underscores the value of basic science in identifying natural biological mechanisms that could be harnessed for clinical benefit. However, the findings are at an early, preclinical stage, and any potential treatment would require years of additional research and clinical trials before becoming available.
The paper, titled "Ch25h/25HC axis orchestrates phagocytosis and lipid metabolism after intracerebral haemorrhage," is published in the Journal of Neuroinflammation.